Chargement en cours...

Inhibition of lung tumorigenesis by metformin is associated with decreased plasma IGF-I and diminished receptor tyrosine kinase signaling

Metformin is the most commonly prescribed drug for type II diabetes and is associated with decreased cancer risk. Previously, we showed that metformin prevented tobacco carcinogen (NNK)-induced lung tumorigenesis in a non-diabetic mouse model, which was associated with decreased IGF-I/insulin recept...

Description complète

Enregistré dans:
Détails bibliographiques
Auteurs principaux: Quinn, Brendan J., Dallos, Matthew, Kitagawa, Hiroshi, Kunnumakkara, Ajaikumar B., Memmott, Regan M., Hollander, M. Christine, Gills, Joell J., Dennis, Phillip A.
Format: Artigo
Langue:Inglês
Publié: 2013
Sujets:
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC3740378/
https://ncbi.nlm.nih.gov/pubmed/23771523
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1158/1940-6207.CAPR-13-0058-T
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!